Ranbaxy

Ranbaxy to restart production of generic version of cholesterol-lowering drug Lipitor

25 Feb 2013

Ranbaxy recalls generic Lipitor in US market over glass particles in bottles

24 Nov 2012

Ranbaxy to invest $40 million to set up a second plant in Malaysia

13 Sep 2012

Ranbaxy in licensing pact with Gilead for HIV drug

03 Aug 2012

Daiichi Sankyo to market Ranbaxy drugs in Venezuela

20 Jun 2012

Ranbaxy rides a generic sales boom to a Rs1,247-crore Q4 net profit

09 May 2012

Ranbaxy launches India's first new drug for malaria, Synriam

25 Apr 2012

Ranbaxy begins US exports of generic Lipitor from Mohali

02 Apr 2012

Ranbaxy opens new manufacturing facility in Morocco

12 Mar 2012

Ranbaxy launches cholesterol-lowering drug `Atorvastatin’ in Europe

06 Mar 2012

View details about the software product Informachine News Trackers

Latest articles

Houthi missile ambitions challenge Saudi air defenses and infrastructure

 Houthi missile ambitions challenge Saudi air defenses and infrastructure

Telangana woos Hyundai for car plant as ₹8,528 crore R&D hub advances

 Telangana woos Hyundai for car plant as ₹8,528 crore R&D hub advances

Uttar Pradesh plans 1,000-acre data centre and IT hub in Bundelkhand

 Uttar Pradesh plans 1,000-acre data centre and IT hub in Bundelkhand

Germany prepares Nvidia pact to advance industrial AI and robotics

 Germany prepares Nvidia pact to advance industrial AI and robotics

Waymo targets Toronto for its first Canadian robotaxi launch in 2028

 Waymo targets Toronto for its first Canadian robotaxi launch in 2028

India’s AI data centre boom could drive renewable power demand

 India’s AI data centre boom could drive renewable power demand

ACG orders 75 Airbus A320neo Family jets in record $11.8B deal

 ACG orders 75 Airbus A320neo Family jets in record $11.8B deal

Reliance welcomes Starlink as Jio awaits satellite clearances ahead of IPO

 Reliance welcomes Starlink as Jio awaits satellite clearances ahead of IPO

DexForce reaches $1.4 billion valuation with synthetic robot training

 DexForce reaches $1.4 billion valuation with synthetic robot training